Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40
ASCO Publishes Guidelines For Dosing Chemotherapy Correctly in Obese Patients
Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival
Researchers Link Cancer Risk And DMPA Birth Control Use
Breast-Conserving Procedures Lead To Frequent Follow-up Care
False-Positive Mammograms Can Indicate Higher Cancer Risk
Proposed Surveillance Model Aims To Reduce Post-Treatment Pain
Adding Avastin Did Not Improve Standard Chemotherapy Regimen
Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas
Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial
Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options
Translplants Not Best Choice in Subset of ALL Patients
PET Response Can Predict Increased Survival In Patients
Cancer Incidence Rates Climb In HIV-Positive Female Populations
Technology Isolates and Recovers Circulating Liver Tumor Cells
Survey Shows That One-Third Of Patients Are Undertreated
Trials Approved by NCI CTEP For the Month of April
FDA Approves Votrient For Soft Tissue Sarcomas
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”
